Q2 2026 saw an 18% year-over-year sales increase to $756 million and net income surged to $19.9 million, driven by strong demand in Medical, AC&C, and Semi-Cap sectors. Gross margin improved, restructuring costs were incurred for a site closure, and liquidity remains robust with $315 million in cas…
Q2 2026 saw an 18% year-over-year sales increase to $756 million and net income surged to $19.9 million, driven by strong demand in Medical, AC&C, and Semi-Cap sectors. Gross margin improved, restructuring costs were incurred for a site closure, and liquidity remains robust with $315 million in cash and $509 million in available credit.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
